MAYNE PHARMA GROUP LTD shares surged 86% to A$5.97 on Tuesday morning after Hungary-based RICHTER GEDEON NYRT agreed to a $407.76 million takeover. The buyout values the Australia-based drugmaker at an equity value of A$604 million. The acquisition price represents a 99.4% premium over the stock's Monday close, putting the equity on track for its best session on record.
Mayne Pharma Surges on $408M Takeover Bid
Mayne Pharma shares surged to a one-year high after Hungarian drugmaker Gedeon Richter agreed to acquire the Australian firm for about $408 million. The board unanimously recommended the offer of A$6.40 per share, subject to regulatory approvals.
Xurve View
Insights:
Xurve View







